On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Antonio Ramírez de Arellano

ResearcherPublications, citations & collaboration network

Antonio Ramírez de Arellano is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Antonio Ramírez de Arellano have?

ScholarIQindexed works

Antonio Ramírez de Arellano has 64 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Antonio Ramírez de Arellano have?

ScholarIQcitation count

Antonio Ramírez de Arellano has 492 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Antonio Ramírez de Arellano?

ScholarIQh-index

Antonio Ramírez de Arellano has an h-index of 15 in OpenAlex.

What is the i10-index of Antonio Ramírez de Arellano?

ScholarIQi10-index

Antonio Ramírez de Arellano has an i10-index of 17 in OpenAlex.

What is the OpenAlex record for Antonio Ramírez de Arellano?

ScholarIQopenalex

The OpenAlex for Antonio Ramírez de Arellano is on the source record.

What are the most-cited papers on Antonio Ramírez de Arellano?

ScholarIQmost cited works
The Economic Burden of Insulin-Related Hypoglycemia in Spain
Witesh Parekh, Nicki Hoskins, James Baker‐Knight, Antonio Ramírez de Arellano, Pedro Mezquita Raya
Diabetes Therapy. 201734 CitationsOPEN ACCESS
The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland
Thomas Ward, Tray Brown, Ruth D. Lewis, Melodi Koşaner Kließ, Antonio Ramírez de Arellano, Carol Moreno Quinn
PharmacoEconomics - Open. 202232 CitationsOPEN ACCESS
Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>
Phil McEwan, Piotr Ponikowski, Jason A. Davis, Giuseppe Rosano, Andrew J.S. Coats, Fabio Dorigotti, Donal O'Sullivan, Antonio Ramírez de Arellano, Ewa A. Jankowska
European Journal of Heart Failure. 202131 CitationsOPEN ACCESS
Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin
Antonio Pérez, Pedro Mezquita Raya, Antonio Ramírez de Arellano, Teresa Briones, Barnaby Hunt, William J. Valentine
Diabetes Therapy. 201530 CitationsOPEN ACCESS
Self-Reported Frequency and Impact of Hypoglycemic Events in Spain
Domingo Orozco‐Beltrán, Pedro Mezquita‐Raya, Antonio Ramírez de Arellano, Manuel Galán
Diabetes Therapy. 201430 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial